Guidelines of care for the management of atopic dermatitis

Sidbury, Robert; Tom, Wynnis L.; Bergman, James N.; Cooper, Kevin D.; Silverman, Robert A.; Berger, Timothy G.; Chamlin, Sarah L.; Cohen, David E.; Cordoro, Kelly M.; Davis, Dawn M.; Feldman, Steven R.; Hanifin, Jon M.; Krol, Alfons; Margolis, David J.; Paller, Amy S.; Schwarzenberger, Kathryn; Simpson, Eric L.; Williams, Hywel C; Elmets, Craig A.; Block, Julie; Harrod, Christopher G.; Begolka, Wendy Smith; Eichenfield, Lawrence F.

doi:10.1016/j.jaad.2014.08.038

Cited by 268 publications

(113 citation statements)

References 147 publications

(139 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Because of possible adverse effects or therapy resistance, clinicians should enquire about and encurage patients to give informations about any alternative therapies that are being used. Patients should be advised that AT have not undergone sufficient evaluation of efficacy or safety [2,3]. Due to the lack of evidence-based international standards and data, we can offer some methods only additionally, and not as a real alternative in the treatment of adult AD.…”

Section: Resultsmentioning

confidence: 99%

“…Most of the methods have no effect at all. There are only few data supporting the efficacy of alternative therapies tried for adult AD [2,6,7,[10][11][12].…”

Section: Discussionmentioning

confidence: 99%

“…TCM may have some benefit for AD lesions, but the results are conflicting and reports on serious hepatotoxicity raise potential safety concerns. Well-designed, placebo-controlled clinical trials are warranted to evaluate the efficacy and safety of the use of TCM in adult AD [2,3,[39][40][41][42][43][44][45].…”

Section: Discussionmentioning

confidence: 99%

“…The diagnosis of AD based on the Hanifin-Rajka criteria [1][2][3][4]8]. The youngest patient was 18, the oldest was 66 years old at the time of the study.…”

Section: Methodsmentioning

confidence: 99%

“…The prevalence of AD is increasing worldwide. The prevalence of adulthood AD is 1-3% at present, the number of adult cases may increase further [1][2][3][4][5]. Many patients do not accept the genetic determination and chronic-recurring course of AD.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Is the alternative medicine a real alternative in adult atopic dermatitis? Experiences of 125 patients

Pónyai¹,

Temesvári²,

Kárpáti³

2016

Glob Dermatol

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

“…Most of the methods have no effect at all. There are only few data supporting the efficacy of alternative therapies tried for adult AD [2,6,7,[10][11][12].…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

“…The diagnosis of AD based on the Hanifin-Rajka criteria [1][2][3][4]8]. The youngest patient was 18, the oldest was 66 years old at the time of the study.…”

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Is the alternative medicine a real alternative in adult atopic dermatitis? Experiences of 125 patients

Pónyai¹,

Temesvári²,

Kárpáti³

2016

Glob Dermatol

View full text Add to dashboard Cite

show abstract

Comparison of Dermatology and Allergy Guidelines for Atopic Dermatitis Management

Mohan

Lio

2015

JAMA Dermatol

View full text Add to dashboard Cite

show abstract

Industry Influence in Dermatology Clinical Practice Guideline Development

Katz

2017

JAMA Dermatol

View full text Add to dashboard Cite

In his farewell address to the nation, in 1961, President Dwight D. Eisenhower warned about the rising influence of the military establishment and the arms industry. "The potential for the disastrous rise of misplaced power exists," the President said, referring to the military-industrial complex, "and will persist." 1 Forty years after that speech, as I began my dermatology residency, another complex with potential for misplaced power was ascending: the dermatology-industrial complex. Topical calcineurin inhibitors for atopic dermatitis and biologic drugs for psoriasis had just arrived, and marketing efforts werepardon the pun-on steroids.Industry was my partner, I was taught, as I learned to be a dermatologist. Indeed, I learned by reading textbooks and journals gifted to me by pharmaceutical companies and their representatives; attended lectures by drug company reps and industry-paid "thought leaders" at industry-sponsored events; provided patients with prescription and nonprescription drug samples from closets stocked by drug company reps, who also offered freebies for personal use ("You can have a lifetime supply," one would promise, referring to his company's moisturizers. "You just can't have it all at once!"); and went to the American Academy of Dermatology's (AAD) annual meeting-itself underwritten in large part by industry "partners"courtesy of pharmaceutical companies, which during the days distributed not only free samples but also companymonogrammed bags in which to carry them, and during the evenings hosted lavish parties, with free booze and, occasionally, a performance by a B-list celebrity (no offense, Pat Benatar; thanks for rocking out during the AAD meeting in New Orleans in 2002).In the years since I completed residency, the pendulum has in some ways swung in the other direction. I now decline free lunches, swag, party invitations, and other goodies offered by pharmaceutical companies. Many institutionsincluding Kaiser Permanente, where I work-have banned prescription drug samples and drug company-sponsored lunches. More broadly, the Institute of Medicine has recommended policies and procedures to mitigate conflicts of interest (COIs) arising from physician-industry interactions in medical research, education, and practice. 2 What about industry influence in dermatology clinical practice guidelines (CPGs)? Industry ties among CPG contributors have been reported, 3 and a study by Checketts et al 4 published in this issue of JAMA Dermatology seeks to address that

show abstract

Guidelines of care for the management of atopic dermatitis

Cited by 268 publications

References 147 publications

Is the alternative medicine a real alternative in adult atopic dermatitis? Experiences of 125 patients

Is the alternative medicine a real alternative in adult atopic dermatitis? Experiences of 125 patients

Comparison of Dermatology and Allergy Guidelines for Atopic Dermatitis Management

Industry Influence in Dermatology Clinical Practice Guideline Development

Contact Info

Product

Resources

About